Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai No 1 Pharmacy CoSHSE:600833 -1.96%56 EV-to-FCF is 28.34 as of Jul. 21, 2026, which is 1% above its 10-year median of 28.03. GuruFocus rates SHSE:600833 with a GF Score™ of 56/100 and a GF Value™ of ¥12.83 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 405 Healthcare Providers & Services companies, Shanghai No 1 Pharmacy Co ranks worse than 67.9% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai No 1 Pharmacy Co's Enterprise Value is ¥1,997 Mil.
Shanghai No 1 Pharmacy Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥70 Mil. Therefore, Shanghai No 1 Pharmacy Co's EV-to-FCF for today is 28.34.
The historical rank and industry rank for Shanghai No 1 Pharmacy Co's EV-to-FCF or its related term are showing as below:
SHSE:600833'
s EV-to-FCF Range Over the Past 10 Years
Min: -959.31 Med: 28.03 Max: 736.83
Current: 27.74
During the past 13 years, the highest EV-to-FCF of Shanghai No 1 Pharmacy Co was 736.83. The lowest was -959.31. And the median was 28.03.
SHSE:600833's EV-to-FCF is ranked worse than 67.9% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 18.06
vs SHSE:600833: 27.74
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai No 1 Pharmacy Co (SHSE:600833) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai No 1 Pharmacy Co's PE Ratio (TTM) for today is calculated as:
Shanghai No 1 Pharmacy Co's share price for today is ¥9.48.
Shanghai No 1 Pharmacy Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.343.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai No 1 Pharmacy Co EV-to-FCF Related Terms
Shanghai No 1 Pharmacy Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai No 1 Pharmacy Co EV-to-FCF Competitor Comparison
For the Pharmaceutical Retailers subindustry, Shanghai No 1 Pharmacy Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai No 1 Pharmacy Co EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Shanghai No 1 Pharmacy Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai No 1 Pharmacy Co's EV-to-FCF falls into.
Shanghai No 1 Pharmacy Co's current Enterprise Value is ¥1,997 Mil.
Shanghai No 1 Pharmacy Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai No 1 Pharmacy Co (SHSE:600833) has a EV-to-FCF of 28.34 as of Jul. 21, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai No 1 Pharmacy Co and its competitors. This is near median its historical median of 28.03. According to the industry distribution chart, Shanghai No 1 Pharmacy Co ranks #275 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 67.9%.
Is Shanghai No 1 Pharmacy Co's EV-to-FCF too high?
Shanghai No 1 Pharmacy Co's current EV-to-FCF of 28.34 is near median its 10-year median of 28.03. The Healthcare Providers & Services industry median EV-to-FCF is 18.06. Shanghai No 1 Pharmacy Co's value of 28.34 is 56.9% above this industry median. Based on the distribution chart, Shanghai No 1 Pharmacy Co ranks #275 out of 405 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Shanghai No 1 Pharmacy Co has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai No 1 Pharmacy Co's EV-to-FCF compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Shanghai No 1 Pharmacy Co ranks #275 out of 405 companies for EV-to-FCF. This places Shanghai No 1 Pharmacy Co in the lower half of its industry. The industry median EV-to-FCF is 18.06. Shanghai No 1 Pharmacy Co's value of 28.34 is 56.9% above this benchmark. While the company's 10-year median is 28.03 vs. the industry median of 18.06, Shanghai No 1 Pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 18.06, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai No 1 Pharmacy Co's current EV-to-FCF of 28.34 is 56.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai No 1 Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 18.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai No 1 Pharmacy Co's current EV-to-FCF is 28.34, which is near median its own 10-year median of 28.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai No 1 Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co (SHSE:600833) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥12.83, compared to a current price of ¥9.48 — trading 26.1% below its estimated fair value. The current EV-to-FCF is 28.34, which is near median its 10-year median of 28.03 and 56.9% above the Healthcare Providers & Services industry median of 18.06. Shanghai No 1 Pharmacy Co's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai No 1 Pharmacy Co (SHSE:600833), the current EV-to-FCF is 28.34 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai No 1 Pharmacy Co (SHSE:600833) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co stock appears to be undervalued.
The current stock price of ¥9.48 is trading 26.1% below its estimated GF Value™ of ¥12.83.
GuruFocus considers Shanghai No 1 Pharmacy Co to be Modestly Undervalued.
Key valuation signals for SHSE:600833:
EV-to-FCF: 28.34 (near median its 10-year median of 28.03)
GF Value™: ¥12.83 vs. price of ¥9.48 (26.1% below fair value)
Industry Position: 56.9% above the Healthcare Providers & Services median (#275 of 405)
No single metric tells the full story. See the SHSE:600833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai No 1 Pharmacy Co Ltd is engaged in pharmaceutical retail and wholesale in China. The company's product profile include Lei Shi Pearl Powder, Tongrentang Ejiao Powder, Wanshuntang Yangyin mouth fragrance mixture, and others. It also provides Nourishing health Nutrition, Medical instruments, Rehabilitation care, Contact lens, and others.
56GF Score
Get the complete analysis for SHSE:600833
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600833 has been successfully added to your 
